These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 28754611)

  • 1. Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis.
    González-Vázquez P; Larrañeta E; McCrudden MTC; Jarrahian C; Rein-Weston A; Quintanar-Solares M; Zehrung D; McCarthy H; Courtenay AJ; Donnelly RF
    J Control Release; 2017 Nov; 265():30-40. PubMed ID: 28754611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapidly dissolving bilayer microneedle arrays - A minimally invasive transdermal drug delivery system for vitamin B12.
    Ramöller IK; Tekko IA; McCarthy HO; Donnelly RF
    Int J Pharm; 2019 Jul; 566():299-306. PubMed ID: 31150773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery.
    Pamornpathomkul B; Ngawhirunpat T; Tekko IA; Vora L; McCarthy HO; Donnelly RF
    Eur J Pharm Sci; 2018 Aug; 121():200-209. PubMed ID: 29777854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs.
    McCrudden MT; Alkilani AZ; McCrudden CM; McAlister E; McCarthy HO; Woolfson AD; Donnelly RF
    J Control Release; 2014 Apr; 180(100):71-80. PubMed ID: 24556420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
    Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
    Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
    Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
    J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, Evaluation, and Pharmacokinetic Assessment of Polymeric Microarray Patches for Transdermal Delivery of Vancomycin Hydrochloride.
    Ramadon D; Permana AD; Courtenay AJ; McCrudden MTC; Tekko IA; McAlister E; Anjani QK; Utomo E; McCarthy HO; Donnelly RF
    Mol Pharm; 2020 Sep; 17(9):3353-3368. PubMed ID: 32706591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery.
    Garland MJ; Caffarel-Salvador E; Migalska K; Woolfson AD; Donnelly RF
    J Control Release; 2012 Apr; 159(1):52-9. PubMed ID: 22265694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing intradermal delivery of tofacitinib citrate: Comparison between powder-loaded hollow microneedle arrays and dissolving microneedle arrays.
    Cárcamo-Martínez Á; Mallon B; Anjani QK; Domínguez-Robles J; Utomo E; Vora LK; Tekko IA; Larrañeta E; Donnelly RF
    Int J Pharm; 2021 Jan; 593():120152. PubMed ID: 33301867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays.
    Garland MJ; Migalska K; Tuan-Mahmood TM; Raghu Raj Singh T; Majithija R; Caffarel-Salvador E; McCrudden CM; McCarthy HO; David Woolfson A; Donnelly RF
    Int J Pharm; 2012 Sep; 434(1-2):80-9. PubMed ID: 22669101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogel-forming microneedles prepared from "super swelling" polymers combined with lyophilised wafers for transdermal drug delivery.
    Donnelly RF; McCrudden MT; Zaid Alkilani A; Larrañeta E; McAlister E; Courtenay AJ; Kearney MC; Singh TR; McCarthy HO; Kett VL; Caffarel-Salvador E; Al-Zahrani S; Woolfson AD
    PLoS One; 2014; 9(10):e111547. PubMed ID: 25360806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local dermal delivery of cyclosporin A, a hydrophobic and high molecular weight drug, using dissolving microneedles.
    Jeong HR; Kim JY; Kim SN; Park JH
    Eur J Pharm Biopharm; 2018 Jun; 127():237-243. PubMed ID: 29432892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin.
    Seong KY; Seo MS; Hwang DY; O'Cearbhaill ED; Sreenan S; Karp JM; Yang SY
    J Control Release; 2017 Nov; 265():48-56. PubMed ID: 28344013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery.
    Migalska K; Morrow DI; Garland MJ; Thakur R; Woolfson AD; Donnelly RF
    Pharm Res; 2011 Aug; 28(8):1919-30. PubMed ID: 21437789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A facile system to evaluate in vitro drug release from dissolving microneedle arrays.
    Larrañeta E; Stewart S; Fallows SJ; Birkhäuer LL; McCrudden MT; Woolfson AD; Donnelly RF
    Int J Pharm; 2016 Jan; 497(1-2):62-9. PubMed ID: 26621687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative approach for potential scale-up to jump-start simplified management of sick young infants with possible serious bacterial infection when a referral is not feasible: Findings from implementation research.
    Leul A; Hailu T; Abraham L; Bayray A; Terefe W; Godefay H; Fantaye M; Qazi SA; Aboubaker S; Nisar YB; Bahl R; Tekle E; Mulugeta A
    PLoS One; 2021; 16(2):e0244192. PubMed ID: 33544712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations in the sterile manufacture of polymeric microneedle arrays.
    McCrudden MT; Alkilani AZ; Courtenay AJ; McCrudden CM; McCloskey B; Walker C; Alshraiedeh N; Lutton RE; Gilmore BF; Woolfson AD; Donnelly RF
    Drug Deliv Transl Res; 2015 Feb; 5(1):3-14. PubMed ID: 25787335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.
    Nasiri MI; Vora LK; Ershaid JA; Peng K; Tekko IA; Donnelly RF
    Drug Deliv Transl Res; 2022 Apr; 12(4):881-896. PubMed ID: 34939170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-Photon Polymerisation 3D Printing of Microneedle Array Templates with Versatile Designs: Application in the Development of Polymeric Drug Delivery Systems.
    Cordeiro AS; Tekko IA; Jomaa MH; Vora L; McAlister E; Volpe-Zanutto F; Nethery M; Baine PT; Mitchell N; McNeill DW; Donnelly RF
    Pharm Res; 2020 Aug; 37(9):174. PubMed ID: 32856172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.